109 related articles for article (PubMed ID: 24101467)
1. Menin promotes hepatocellular carcinogenesis and epigenetically up-regulates Yap1 transcription.
Xu B; Li SH; Zheng R; Gao SB; Ding LH; Yin ZY; Lin X; Feng ZJ; Zhang S; Wang XM; Jin GH
Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17480-5. PubMed ID: 24101467
[TBL] [Abstract][Full Text] [Related]
2. Scaffolding Protein IQGAP1 Is Dispensable, but Its Overexpression Promotes Hepatocellular Carcinoma via YAP1 Signaling.
Delgado ER; Erickson HL; Tao J; Monga SP; Duncan AW; Anakk S
Mol Cell Biol; 2021 Mar; 41(4):. PubMed ID: 33526450
[TBL] [Abstract][Full Text] [Related]
3. An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma.
Sun H; Yang W; Tian Y; Zeng X; Zhou J; Mok MTS; Tang W; Feng Y; Xu L; Chan AWH; Tong JH; Cheung YS; Lai PBS; Wang HKS; Tsang SW; Chow KL; Hu M; Liu R; Huang L; Yang B; Yang P; To KF; Sung JJY; Wong GLH; Wong VWS; Cheng ASL
Nat Commun; 2018 Dec; 9(1):5214. PubMed ID: 30523261
[TBL] [Abstract][Full Text] [Related]
4. Menin and Daxx Interact to Suppress Neuroendocrine Tumors through Epigenetic Control of the Membrane Metallo-Endopeptidase.
Feng Z; Wang L; Sun Y; Jiang Z; Domsic J; An C; Xing B; Tian J; Liu X; Metz DC; Yang X; Marmorstein R; Ma X; Hua X
Cancer Res; 2017 Jan; 77(2):401-411. PubMed ID: 27872097
[TBL] [Abstract][Full Text] [Related]
5. LRPPRC sustains Yap-P27-mediated cell ploidy and P62-HDAC6-mediated autophagy maturation and suppresses genome instability and hepatocellular carcinomas.
Li W; Dai Y; Shi B; Yue F; Zou J; Xu G; Jiang X; Wang F; Zhou X; Liu L
Oncogene; 2020 May; 39(19):3879-3892. PubMed ID: 32203162
[TBL] [Abstract][Full Text] [Related]
6. Menin Maintains Cholesterol Content in Colorectal Cancer via Repression of LXR-Mediated Transcription.
Nyul TE; Beyries K; Hojnacki T; Glynn R; Paulosky KE; Gedela A; Majer A; Altman L; Buckley KH; Feng Z; Sun K; Peng Z; Tobias JW; Hua X; Katona BW
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627154
[TBL] [Abstract][Full Text] [Related]
7. The functional and mechanistic relatedness of EZH2 and menin in hepatocellular carcinoma.
Gao SB; Xu B; Ding LH; Zheng QL; Zhang L; Zheng QF; Li SH; Feng ZJ; Wei J; Yin ZY; Hua X; Jin GH
J Hepatol; 2014 Oct; 61(4):832-9. PubMed ID: 24845612
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic inhibition of the Menin-MLL interaction blocks progression of MLL leukemia in vivo.
Borkin D; He S; Miao H; Kempinska K; Pollock J; Chase J; Purohit T; Malik B; Zhao T; Wang J; Wen B; Zong H; Jones M; Danet-Desnoyers G; Guzman ML; Talpaz M; Bixby DL; Sun D; Hess JL; Muntean AG; Maillard I; Cierpicki T; Grembecka J
Cancer Cell; 2015 Apr; 27(4):589-602. PubMed ID: 25817203
[TBL] [Abstract][Full Text] [Related]
9. Targeting the MLL complex in castration-resistant prostate cancer.
Malik R; Khan AP; Asangani IA; Cieślik M; Prensner JR; Wang X; Iyer MK; Jiang X; Borkin D; Escara-Wilke J; Stender R; Wu YM; Niknafs YS; Jing X; Qiao Y; Palanisamy N; Kunju LP; Krishnamurthy PM; Yocum AK; Mellacheruvu D; Nesvizhskii AI; Cao X; Dhanasekaran SM; Feng FY; Grembecka J; Cierpicki T; Chinnaiyan AM
Nat Med; 2015 Apr; 21(4):344-52. PubMed ID: 25822367
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of autophagy as a new means of improving chemotherapy efficiency in high-LC3B triple-negative breast cancers.
Lefort S; Joffre C; Kieffer Y; Givel AM; Bourachot B; Zago G; Bieche I; Dubois T; Meseure D; Vincent-Salomon A; Camonis J; Mechta-Grigoriou F
Autophagy; 2014; 10(12):2122-42. PubMed ID: 25427136
[TBL] [Abstract][Full Text] [Related]
11. The same site on the integrase-binding domain of lens epithelium-derived growth factor is a therapeutic target for MLL leukemia and HIV.
Murai MJ; Pollock J; He S; Miao H; Purohit T; Yokom A; Hess JL; Muntean AG; Grembecka J; Cierpicki T
Blood; 2014 Dec; 124(25):3730-7. PubMed ID: 25305204
[TBL] [Abstract][Full Text] [Related]
12. Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain.
Bartsch DK; Slater EP; Albers M; Knoop R; Chaloupka B; Lopez CL; Fendrich V; Kann PH; Waldmann J
J Clin Endocrinol Metab; 2014 Nov; 99(11):E2387-91. PubMed ID: 25210877
[TBL] [Abstract][Full Text] [Related]
13. Menin determines K-RAS proliferative outputs in endocrine cells.
Chamberlain CE; Scheel DW; McGlynn K; Kim H; Miyatsuka T; Wang J; Nguyen V; Zhao S; Mavropoulos A; Abraham AG; O'Neill E; Ku GM; Cobb MH; Martin GR; German MS
J Clin Invest; 2014 Sep; 124(9):4093-101. PubMed ID: 25133424
[TBL] [Abstract][Full Text] [Related]
14. Challenges and opportunities in targeting the menin-MLL interaction.
Cierpicki T; Grembecka J
Future Med Chem; 2014 Mar; 6(4):447-62. PubMed ID: 24635524
[TBL] [Abstract][Full Text] [Related]
15. Switch enhancers interpret TGF-β and Hippo signaling to control cell fate in human embryonic stem cells.
Beyer TA; Weiss A; Khomchuk Y; Huang K; Ogunjimi AA; Varelas X; Wrana JL
Cell Rep; 2013 Dec; 5(6):1611-24. PubMed ID: 24332857
[TBL] [Abstract][Full Text] [Related]
16. Transformation by Hras(G12V) is consistently associated with mutant allele copy gains and is reversed by farnesyl transferase inhibition.
Chen X; Makarewicz JM; Knauf JA; Johnson LK; Fagin JA
Oncogene; 2014 Nov; 33(47):5442-9. PubMed ID: 24240680
[TBL] [Abstract][Full Text] [Related]
17. Itaconate inhibits corticosterone-induced necroptosis and neuroinflammation via up-regulating menin in HT22 cells.
Liang JY; Gao S; Jiang JM; Zhang P; Zou W; Tang XQ; Tang YY
J Physiol Biochem; 2024 May; 80(2):393-405. PubMed ID: 38427168
[TBL] [Abstract][Full Text] [Related]
18. The risk of concurrent malignancies in patients with multiple endocrine neoplasia type 1: insights into clinical characteristics of those with multiple endocrine neoplasia type 1.
Zhao YX; Wang O; Song A; Wang LJ; Gong FY; Duan L; Yang HB; Pan H; Zhu HJ
J Endocrinol Invest; 2023 Dec; ():. PubMed ID: 38161202
[TBL] [Abstract][Full Text] [Related]
19. Menin orchestrates hepatic glucose and fatty acid uptake via deploying the cellular translocation of SIRT1 and PPARγ.
Liu T; Li R; Sun L; Xu Z; Wang S; Zhou J; Wu X; Shi K
Cell Biosci; 2023 Sep; 13(1):175. PubMed ID: 37740216
[TBL] [Abstract][Full Text] [Related]
20. Menin-MLL1 Interaction Small Molecule Inhibitors: A Potential Therapeutic Strategy for Leukemia and Cancers.
Shi Q; Xu M; Kang Z; Zhang M; Luo Y
Molecules; 2023 Mar; 28(7):. PubMed ID: 37049787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
